Jump to ContentJump to Main Navigation
Me Medicine vs. We Medicine – Reclaiming Biotechnology for the Common Good - Columbia Scholarship Online
Users without a subscription are not able to see the full content.

Me Medicine vs. We Medicine: Reclaiming Biotechnology for the Common Good

Donna Dickenson


Personalized healthcare—or what this book calls “Me Medicine”—is radically transforming the US’s longstanding “one-size-fits-all” model. Technologies such as direct-to-consumer genetic testing, pharmacogenetically developed therapies in cancer care, private umbilical cord blood banking, and neurocognitive enhancement claim to cater to an individual’s specific biological character, and, in some cases, these technologies have shown powerful potential. Yet in others they have produced negligible or even negative results. Whatever is behind the rise of Me Medicine, it is not just science. So why i ... More

Keywords: personalized healthcare, Me Medicine, cancer care, biological character, We Medicine, vaccination, public-health infrastructure, blood banks, retail genetics

Bibliographic Information

Print publication date: 2016 Print ISBN-13: 9780231159753
Published to Columbia Scholarship Online: November 2015 DOI:10.7312/columbia/9780231159753.001.0001


Affiliations are at time of print publication.

Donna Dickenson, author